Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ·Healthcare·Biotechnology
$33.68
-0.44%
Mkt Cap $2.05B
Analyst Ratings
Buy
3
Hold
3
Sell
1
Price Target (19 analysts)
$46.80
Range $31.00 – $62.00
Implied Upside
+39.0%
Consensus $46.80 vs current $33.68